Y Intercept Hong Kong Ltd Acquires New Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Y Intercept Hong Kong Ltd bought a new stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) in the third quarter, Holdings Channel reports. The firm bought 8,983 shares of the company’s stock, valued at approximately $648,000.

Other institutional investors also recently bought and sold shares of the company. Ariel Investments LLC boosted its stake in shares of Prestige Consumer Healthcare by 10.7% in the second quarter. Ariel Investments LLC now owns 2,835,203 shares of the company’s stock valued at $195,204,000 after purchasing an additional 274,212 shares during the period. Victory Capital Management Inc. lifted its holdings in Prestige Consumer Healthcare by 9.0% during the 2nd quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company’s stock worth $142,827,000 after buying an additional 171,357 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its position in Prestige Consumer Healthcare by 19.3% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,575,170 shares of the company’s stock valued at $113,570,000 after buying an additional 255,045 shares during the period. Congress Asset Management Co. grew its stake in shares of Prestige Consumer Healthcare by 7.8% in the third quarter. Congress Asset Management Co. now owns 865,123 shares of the company’s stock worth $62,375,000 after acquiring an additional 62,411 shares in the last quarter. Finally, Boston Trust Walden Corp purchased a new stake in shares of Prestige Consumer Healthcare during the third quarter worth $41,785,000. 99.95% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on PBH. Sidoti lowered Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 target price for the company. in a report on Monday, December 9th. StockNews.com cut Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday, December 10th. Jefferies Financial Group restated a “hold” rating and set a $76.00 target price (up from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. Finally, DA Davidson reiterated a “buy” rating and issued a $95.00 price target on shares of Prestige Consumer Healthcare in a research note on Monday, November 11th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $85.25.

Insider Activity

In other news, EVP Adel Mekhail sold 9,063 shares of the business’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $82.00, for a total value of $743,166.00. Following the completion of the sale, the executive vice president now directly owns 18,365 shares of the company’s stock, valued at approximately $1,505,930. The trade was a 33.04 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider William P’pool sold 8,987 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $81.85, for a total value of $735,585.95. Following the transaction, the insider now owns 20,058 shares in the company, valued at $1,641,747.30. This represents a 30.94 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 38,810 shares of company stock worth $3,187,300. Corporate insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Stock Down 1.5 %

Shares of NYSE PBH opened at $82.30 on Friday. The business has a 50-day moving average of $78.12 and a two-hundred day moving average of $72.47. The company has a market capitalization of $4.07 billion, a price-to-earnings ratio of 20.02, a price-to-earnings-growth ratio of 2.35 and a beta of 0.49. Prestige Consumer Healthcare Inc. has a 1 year low of $57.95 and a 1 year high of $86.36. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.56 and a quick ratio of 2.10.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, hitting the consensus estimate of $1.09. The firm had revenue of $283.79 million during the quarter, compared to analysts’ expectations of $282.09 million. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The firm’s revenue was down .9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.07 earnings per share. On average, analysts forecast that Prestige Consumer Healthcare Inc. will post 4.44 earnings per share for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.